Genetic diversity of hepatitis B virus and hepatitis C virus in human immunodeficiency virus type 1-co-infected patients from Venezuela

J Med Microbiol. 2014 Aug;63(Pt 8):1099-1104. doi: 10.1099/jmm.0.067496-0. Epub 2014 Jun 3.

Abstract

The aim of this study was to evaluate the prevalence and genetic diversity of hepatitis B virus (HBV) and hepatitis C virus (HCV) in human immunodeficiency virus type 1 (HIV-1)-co-infected Venezuelan patients. The prevalence of HBV and HCV markers of infection in HIV-1 patients was 14% for anti-hepatitis B core antigen, 3% for hepatitis B surface antigen and 0.7% for anti-HCV, respectively. HBV prevalence was higher than HCV, as expected for a country where sexual intercourse, not intravenous drug use, is the main mode of HIV-1 transmission. The HCV genotype distribution in HIV-1-co-infected patients was similar to that obtained in HCV-mono-infected patients, but genotype 1a was more frequent in HIV-1-infected patients. The HBV genotype distribution exhibited differences between mono-infected and HIV-1-co-infected individuals. HBV F3 was the most common subgenotype in both groups, followed by F1b in HIV-1 co-infection and F2 in HBV mono-infection. In addition, genotype G (single infection) was found in an HIV-1-co-infected individual. A high prevalence of occult HBV infection was detected in HIV-1-co-infected naïve patients (18%), with F2 being the most common genotype (75%). To the best of our knowledge, these results correspond to the first description of frequency and molecular characterization of HBV and HCV in HIV-1 Venezuelan patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Coinfection / epidemiology
  • Coinfection / virology*
  • Female
  • Genetic Variation*
  • Genotype
  • HIV Infections / complications*
  • HIV Infections / virology
  • HIV-1
  • Hepacivirus / genetics*
  • Hepatitis B / epidemiology
  • Hepatitis B / virology*
  • Hepatitis B virus / genetics
  • Hepatitis C / epidemiology
  • Hepatitis C / virology*
  • Humans
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Venezuela / epidemiology
  • Young Adult

Associated data

  • GENBANK/KF414631
  • GENBANK/KF414632
  • GENBANK/KF414633
  • GENBANK/KF414634
  • GENBANK/KF414635
  • GENBANK/KF414636
  • GENBANK/KF414637
  • GENBANK/KF414638
  • GENBANK/KF414639
  • GENBANK/KF414640
  • GENBANK/KF414641
  • GENBANK/KF414642
  • GENBANK/KF414643
  • GENBANK/KF414644
  • GENBANK/KF414645
  • GENBANK/KF414646
  • GENBANK/KF414647
  • GENBANK/KF414648
  • GENBANK/KF414649
  • GENBANK/KF414650
  • GENBANK/KF414651
  • GENBANK/KF414652
  • GENBANK/KF414653
  • GENBANK/KF414654
  • GENBANK/KF414655
  • GENBANK/KF414656
  • GENBANK/KF414657
  • GENBANK/KF414658
  • GENBANK/KF414659
  • GENBANK/KF414660
  • GENBANK/KF414661
  • GENBANK/KF414662
  • GENBANK/KF414663
  • GENBANK/KF414664
  • GENBANK/KF414665
  • GENBANK/KF414666
  • GENBANK/KF414667
  • GENBANK/KF414668
  • GENBANK/KF414669
  • GENBANK/KF414670
  • GENBANK/KF414671
  • GENBANK/KF414672
  • GENBANK/KF414673
  • GENBANK/KF414674
  • GENBANK/KF414675
  • GENBANK/KF414676
  • GENBANK/KF414677
  • GENBANK/KF414678
  • GENBANK/KF414679